Detalles de la búsqueda
1.
A phase 1 trial utilizing a pharmacokinetic endpoint to determine the optimal dose of ramucirumab in children and adolescents with relapsed or refractory solid tumors, including central nervous system tumors.
Pediatr Blood Cancer
; 71(3): e30817, 2024 Mar.
Artículo
Inglés
| MEDLINE | ID: mdl-38189770
2.
Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1-2 trial.
Lancet Oncol
; 21(4): 541-550, 2020 04.
Artículo
Inglés
| MEDLINE | ID: mdl-32192573
3.
ADVL1522: A phase 2 study of lorvotuzumab mertansine (IMGN901) in children with relapsed or refractory wilms tumor, rhabdomyosarcoma, neuroblastoma, pleuropulmonary blastoma, malignant peripheral nerve sheath tumor, or synovial sarcoma-A Children's Oncology Group study.
Cancer
; 126(24): 5303-5310, 2020 12 15.
Artículo
Inglés
| MEDLINE | ID: mdl-32914879
4.
Do intravenous fluid substitutions influence methotrexate clearance? An unanticipated impact of an intravenous sodium bicarbonate drug shortage.
Pediatr Blood Cancer
; 67(9): e28334, 2020 09.
Artículo
Inglés
| MEDLINE | ID: mdl-32608575
5.
Phase 1/2 trial of talazoparib in combination with temozolomide in children and adolescents with refractory/recurrent solid tumors including Ewing sarcoma: A Children's Oncology Group Phase 1 Consortium study (ADVL1411).
Pediatr Blood Cancer
; 67(2): e28073, 2020 02.
Artículo
Inglés
| MEDLINE | ID: mdl-31724813
6.
Essential medicines for childhood cancer in Europe.
Lancet Oncol
; 24(2): e67, 2023 02.
Artículo
Inglés
| MEDLINE | ID: mdl-36725147
7.
A study of axitinib, a VEGF receptor tyrosine kinase inhibitor, in children and adolescents with recurrent or refractory solid tumors: A Children's Oncology Group phase 1 and pilot consortium trial (ADVL1315).
Cancer
; 124(23): 4548-4555, 2018 12 01.
Artículo
Inglés
| MEDLINE | ID: mdl-30394521
8.
A phase 1 study of eribulin mesylate (E7389), a novel microtubule-targeting chemotherapeutic agent, in children with refractory or recurrent solid tumors: A Children's Oncology Group Phase 1 Consortium study (ADVL1314).
Pediatr Blood Cancer
; 65(8): e27066, 2018 08.
Artículo
Inglés
| MEDLINE | ID: mdl-29719113
9.
One-on-one care management and procurement of Naloxone for ambulatory use.
J Public Health (Oxf)
; 40(4): 858-862, 2018 12 01.
Artículo
Inglés
| MEDLINE | ID: mdl-29462351
10.
Using decision modeling to guide drug allocation during a shortage.
Pediatr Blood Cancer
; 64(7)2017 Jul.
Artículo
Inglés
| MEDLINE | ID: mdl-27862980
11.
Dosing anticancer drugs in infants: Current approach and recommendations from the Children's Oncology Group's Chemotherapy Standardization Task Force.
Pediatr Blood Cancer
; 64(11)2017 Nov.
Artículo
Inglés
| MEDLINE | ID: mdl-28509433
12.
Additive effects of vorinostat and MLN8237 in pediatric leukemia, medulloblastoma, and neuroblastoma cell lines.
Invest New Drugs
; 31(1): 39-45, 2013 Feb.
Artículo
Inglés
| MEDLINE | ID: mdl-22669335
13.
A phase-1 pharmacokinetic optimal dosing study of intraventricular topotecan for children with neoplastic meningitis: a Pediatric Brain Tumor Consortium study.
Pediatr Blood Cancer
; 60(4): 627-32, 2013 Apr.
Artículo
Inglés
| MEDLINE | ID: mdl-23002039
14.
Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C.
J Natl Cancer Inst
; 115(11): 1355-1363, 2023 11 08.
Artículo
Inglés
| MEDLINE | ID: mdl-37228094
15.
A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium study.
J Neurooncol
; 106(3): 643-9, 2012 Feb.
Artículo
Inglés
| MEDLINE | ID: mdl-21968943
16.
Phase 2 clinical trial of intrathecal topotecan in children with refractory leptomeningeal leukemia: a Children's Oncology Group trial (P9962).
Pediatr Blood Cancer
; 58(3): 362-5, 2012 Mar.
Artículo
Inglés
| MEDLINE | ID: mdl-21910214
17.
A Phase I/II Trial of Nivolumab plus Ipilimumab in Children and Young Adults with Relapsed/Refractory Solid Tumors: A Children's Oncology Group Study ADVL1412.
Clin Cancer Res
; 28(23): 5088-5097, 2022 12 01.
Artículo
Inglés
| MEDLINE | ID: mdl-36190525
18.
Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial.
J Clin Oncol
; 40(20): 2224-2234, 2022 07 10.
Artículo
Inglés
| MEDLINE | ID: mdl-35353553
19.
Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial.
J Clin Oncol
; 40(20): 2235-2245, 2022 07 10.
Artículo
Inglés
| MEDLINE | ID: mdl-35363510
20.
Educational paper. The development of new therapies for pediatric oncology.
Eur J Pediatr
; 170(5): 555-9, 2011 May.
Artículo
Inglés
| MEDLINE | ID: mdl-21190039